Abstract
ObjectivesThis study aimed to develop and assess the feasibility and cost impact of an intervention involving a practice pharmacist embedded in general practice to improve prescribing safety, deprescribe where appropriate and reduce costs.SettingFour-doctor suburban general practice.ParticipantsInclusion criteria: patients receiving 10+ repeat drugs per month. Exclusion criteria: deceased, <18 years of age, nursing home resident, no longer attending, late-stage life-limiting condition, unsuitable on clinical/capacity grounds. 137 patients were eligible. 78 were recruited as participants, all of whom completed the study.InterventionPharmacist conducting holistic medication reviews in the study group over a 6-month period.Primary outcome measuresAnonymised medication changes, cost, biochemical monitoring and clinical measurements data were collected. Cost analysis of having a pharmacist as part of the general practice team was calculated.ResultsIn total, 198 potentially inappropriate prescriptions (PIPs), and 163 opportunities for deprescribing were identified; 127 PIPs (64.1%) were actioned; 104 deprescribing opportunities were actioned (63.8%). The pharmacist identified 101 instances in which further investigations were warranted prior to prescription issue, of which 80 were actioned (79.2%). It was calculated that monthly savings of €1252 were made as a result of deprescribing.ConclusionsThis study has shown that the integration of pharmacists within general practice in Ireland is feasible and is an effective means of improving prescribing safety and implementing deprescribing through medication reviews. The combination of safety and cost concerns support taking a holistic approach to deprescribing with the patient. This study highlights the ease with which a pharmacist could integrate into the general practice setting in Ireland and points to how this could be sustainably funded.
Reference51 articles.
1. World Health Organisation . The World Medicines Situation [Internet], 2004. Available: https://www.who.int/medicines/areas/policy/world_medicines_situation/en/
2. World Health Organisation . Medication safety in polypharmacy: technical report [Internet], 2019. Available: https://www.who.int/publications/i/item/medication-safety-in-polypharmacy-technical-report
3. What is polypharmacy? A systematic review of definitions
4. National Institute for Health and Care Excellence (NICE) . Multimorbidity and polypharmacy [Internet], 2019. Available: https://www.nice.org.uk/advice/ktt18
5. Polypharmacy: one of the greatest prescribing challenges in general practice
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献